Translator Disclaimer
17 June 2002 Preclinical evaluation of 5-ALA-based PDT for the treatment of canine urinary bladder cancer: fluorescence distribution and response of normal urinary bladder tissue
Author Affiliations +
Proceedings Volume 4609, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XII; (2002) https://doi.org/10.1117/12.440961
Event: International Symposium on Biomedical Optics, 2002, San Jose, CA, United States
Abstract
Photodynamic therapy (PDT) is a potential improvement over conventional therapy for urinary bladder cancer, especially using the pro-photosensitizer 5-aminolevulinic acid (ALA), which is metabolized to its active form, protoporphyrin IX (PpIX), within both normal and neoplastic epithelial tissue. The purpose of this study was to evaluate ALA-based PDT in healthy dogs as a prelude to treating dogs with transitional cell carcinoma of the urinary bladder. Methods: Twelve dogs were given oral ALA at 0, 30, 60, or 90 mg/kg. Four hours later, the dogs were sacrificed and bladder tissue was collected and frozen for low-intensity fluorescence microscopy. Fifteen dogs were given oral ALA at 0, 30, 60, or 90 mg/kg and anesthetized four hours later. The trigone was irradiated with 635 nm laser light. All dogs were necropsied after PDT (48 h or 21 d). Results: PpIX fluorescence was confined to the urinary bladder mucosa with no detectable fluorescence in the muscularis or serosa. Histopathological lesions after PDT were limited to mild inflammation. Conclusions: Oral ALA appears to be well tolerated by healthy dogs at the dosages used. Because PpIX fluorescence was confined to the mucosa, ALA-based PDT may be a useful treatment for canine lower urinary tract neoplasia.
© (2002) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Michael D. Lucroy D.V.M., George M. Peavy D.V.M., Tisha Ridgway, Russell G. Higbee, Gregory A. Campbell, Tiffany A. Healey, and Kenneth Eugene Bartels D.V.M. "Preclinical evaluation of 5-ALA-based PDT for the treatment of canine urinary bladder cancer: fluorescence distribution and response of normal urinary bladder tissue", Proc. SPIE 4609, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XII, (17 June 2002); https://doi.org/10.1117/12.440961
PROCEEDINGS
4 PAGES


SHARE
Advertisement
Advertisement
Back to Top